Solvothermal Synthesis of Multiple Dihydropyrimidinones at a Time as Inhibitors of Eg5

Abstract

Solvothermal synthesis of multiple dihydropyrimidinones at a time has been developed in inexpensive and green bio-based solvent lactic acid without any additional catalysts or additives. By this method, thirty new dihydropyrimidinone derivatives were synthesized in two batches and characterized. All of the compounds were screened by Eg5 motor protein ATPase assay, and the positive compounds were tested against the Caco-2 cell line, HeLa cell line, L929 cell line and T24 cell line in vitro. Among them, compound C9 exhibited the best inhibitory activity against motor protein ATPase with an IC50 value of 30.25 μM and significant cytotoxic activity in the micromolar range against the cells above. The Lineweaver–Burk plot revealed that compound C9 was a mixed-type Eg5 inhibitor. A molecular modeling study using the Discovery Studio program was performed, where compound C9 exhibited good binding interaction with Eg5 motor protein ATPase, and this was consistent with the attained experimental results.

Ethyl 5-Formyl-1-(pyridin-3-yl)-1H-1,2,3-triazole-4-carboxylate: Synthesis, Crystal Structure, Hirshfeld Surface Analysis, and DFT Calculation

“…Syntheses of (+)-Rubellin C [5], benzo[f]pyrrolo [1, 2-a] [1,4] diazepines [6], fluorinated isocoumarines [7], furo [2,3-d]pyridazines [8], furo [3,4-c]pyridines [9], 1-oxo-9H-thiopyrano [3,4-b]indoles [10], pyrazoloisoindoles [11], phthalazines [12] and isothiocoumarines [13] were studied. ortho-Formyl acids were used for the synthesis of biologically active compounds with anticancer potential [14]; PROTACs E3 ubiquitin ligase inhibitor [15] and MDM2 [16] degrades; STING [17] and PKM2 [18] modulators; inhibitors of Eg5 [19], SIRT1 and SIRT2 [20], 15lipoxygenase-1 [21] and pyruvate kinase activators [22].…”